CareDX Lab Solutions Inc. Allo Seq Tx17 Next Generation Sequencing (NGS) Reagent Kits
ID: 26-000014Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/workspace/contract/opp/c1365b505a8841c59d9242cad0572b61/view
Timeline
    Description

    The National Institutes of Health (NIH) intends to issue a sole-source firm fixed-price purchase order to CareDx Lab Solutions Inc. for the procurement of Allo Seq Tx17 Next Generation Sequencing (NGS) reagent kits. This acquisition aims to secure a one-year supply of NGS reagents necessary for the Human Leukocyte Antigen (HLA) Laboratory within the Department of Transfusion Medicine, ensuring adequate stock for patient testing through quarterly shipments scheduled for February, May, and August 2026. The HLA Laboratory plays a critical role in providing diagnostic testing and consultations for transplant eligibility, maintaining accreditation, and engaging in research for new diagnostic tests. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by January 10, 2026, at 6:00 AM EST, as this is not a request for proposals.

    Point(s) of Contact
    Shasheshe Goolsby
    (301) 827-4879
    shasheshe.goolsby@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Sole Source – Werfen USA, LLC
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), intends to award a sole source contract to Werfen USA, LLC for the procurement of kits and reagents essential for patient care testing, specifically for use with the ACL TOP 350 and 750 analyzers. This procurement, valued at approximately $570,000 over a base year and two option years (January 1, 2026, to December 31, 2028), is critical as the reagents are uniquely validated for the existing instruments, ensuring continuity in patient care and research protocols. The acquisition will be conducted under the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for increased procedural flexibility and efficiency. Interested parties may submit comments regarding this notice to Ryssa Nix at ryssa.nix@nih.gov by the close date of December 23, 2025, at 12 PM EST.
    NOTICE of Intent to SOLE SOURCE - Biolytic Lab Performance INC
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source firm fixed price purchase order to Biolytic Lab Performance INC for the maintenance and upkeep of Dr. Oligo 48 Medium Throughput DNA Synthesizers. This procurement is critical for ensuring the operational readiness of a laboratory instrument that plays a vital role in standard laboratory operations and public health emergencies, necessitating regular maintenance and access to proprietary codes and OEM parts. Biolytic is uniquely qualified to provide these services due to their trained engineers and exclusive access to genuine OEM parts, with a response time of 24-48 hours for service calls. Interested parties may submit their interest and capability to respond to this requirement via email to the contract specialist by COB January 22, 2026, although this notice is not a request for competitive quotations.
    Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000
    Dept Of Defense
    The Department of Defense, through the Naval Medical Research Center (NMRC), is seeking to award a sole-source contract to Illumina, Inc. for a comprehensive maintenance and repair plan for the Illumina NovaSeq 6000 sequencing instrument. The contract, valued at $145,522, requires full coverage for OEM parts and labor, no-cost replacement of proprietary reagents, one on-site preventative maintenance visit, remote technical support, and on-site response within two business days, among other services. This procurement is critical for maintaining the operational integrity of the NovaSeq 6000, which is essential for various research applications. Interested parties may contact Deborah Sharpe at deborah.m.sharpe2.civ@health.mil or Stephanie Gray at stephanie.r.gray4.civ@health.mil for further information.
    Notice of Intent to Sole Source – Sterility Testing Service LIMS Project
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), has issued a Notice of Intent to Sole Source for additional professional services related to the Sterility Testing Service (STS) Laboratory Information Management System (LIMS) project. The procurement aims to secure extra professional service days to support the configuration and rollout of the Portal, addressing compliance gaps and enhancing process efficiencies identified in the original Statement of Work (SOW). LabVantage, the original vendor for the STS LIMS procurement, is the sole source for these additional services due to their established involvement in the project. Interested parties may submit comments regarding this notice via email to Chris Ryssa Nix at ryssa.nix@nih.gov by January 14, 2026, at 12 PM EST.
    6640--Lab DiaSorin Reagents - VISN23
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 23, intends to award a sole source firm fixed price contract to DIASORIN MOLECULAR LLC for the provision of DiaSorin Reagents to support the Veterans Integrated Service Network 23 (VISN23). The procurement aims to secure FDA-approved quality control kits and consumables, including various Simplexa kits for COVID-19, Flu A/B & RSV, and other critical tests, with specific requirements for long outdates and immediate replacement in case of recalls. These reagents are essential for the operation of multiple lab sites across South Dakota, Iowa, North Dakota, Nebraska, Minnesota, and Wisconsin, ensuring the delivery of vital healthcare services to veterans. Interested vendors who believe they can meet the requirements as authorized resellers must submit their capability statements to Contracting Officer Emanuel Nevarez by January 12, 2026, at 13:00 Central Time, referencing solicitation number 36C26326Q0249.
    Single-Nuclei Multiome Analysis of Human Brain Tissue, iPSC-Derived Cells and Human Dorsal Root Ganglion
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified entities to conduct a Single-Nuclei Multiome Analysis of Human Brain Tissue, iPSC-Derived Cells, and Human Dorsal Root Ganglion. This procurement aims to advance research in medical laboratory testing by analyzing complex biological samples to enhance understanding of neurological conditions. The work is critical for developing innovative treatments and therapies in the field of neuroscience. Interested parties can reach out to Maggie Brant at maggie.brant@nih.gov or KJ Shaikh at KJ.Shaikh@nih.gov for further details regarding this opportunity.
    Notice of Intent to Sole Source – Preventative Maintenance (PM) Service Contract
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole source contract to Peak Scientific, Inc. for preventative maintenance services on their PEAK Genius XE SCI gas generators. The objective of this procurement is to ensure the continuous and efficient operation of the gas generators, which are critical for the mass spectrometer used in patient care testing, thereby facilitating timely results. The contract will cover a one-year base period with three option years, emphasizing the necessity of specialized maintenance services that only Peak Scientific can provide due to their unique training and proprietary tools. Interested parties can direct inquiries to Chris Ryssa Nix at ryssa.nix@nih.gov, with comments on this notice due by January 14, 2026.
    Brand Name Illumina reagents, kits and consumables (BPA)
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to issue a sole source contract for the procurement of brand name Illumina reagents, kits, and consumables, specifically to Bio-Active Co., Ltd in Thailand. This procurement aims to support high-throughput sequencing workflows that are critical for microbial surveillance, viral detection, influenza typing, and gene expression profiling, utilizing products that are validated for compatibility with Illumina sequencing platforms. Interested parties are invited to respond within 15 days with evidence of their ability to provide comparable services; otherwise, the contract will be awarded solely to the identified vendor. For further inquiries, interested parties may contact John Fitzsimmons at john.l.fitzsimmons8.civ@health.mil or by phone at 301-514-2040.
    NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), has issued a Special Notice regarding subcontracting opportunities at the Frederick National Laboratory for Cancer Research (FNLCR). This opportunity focuses on the need for laboratory assays and services to assess cytokines in nasal mucosa samples for up to nine phase 1 trials and two phase 2 trials related to the NextGen COVID-19 vaccine program, which is critical for advancing the National Institute of Allergy and Infectious Diseases (NIAID) mission. The FNLCR, operated by Leidos Biomedical Research, Inc., plays a vital role in cancer and AIDS research, and this notice aims to inform potential subcontractors of the requirements without constituting a formal solicitation. Interested parties can reach out to Tara Phillips at tara.phillips@nih.gov for further details regarding Solicitation/RFP No. S26-111, with a response date set for January 14, 2026.
    OligoCard for DNA Sequencing
    Dept Of Defense
    The Department of Defense, specifically the Naval Research Laboratory (NRL), is seeking a sole-source procurement of OligoCards from Integrated DNA Technologies (IDT) for critical research purposes. This acquisition, valued between $10,000 and $250,000, is justified under FAR 13.106-1(b)(1)(i) due to the urgent need for specialized oligonucleotides and comprehensive sequencing services that only IDT can provide. The OligoCards are vital for advancing molecular biology, biotechnology, and DNA nanotechnology research, particularly in areas such as protein production, threat detection, and sensor development for the Department of Defense. Interested parties can reach out to Brandon Zellers at brandon.zellers@nrl.navy.mil for further information regarding this opportunity.